Medical oncologist at Memorial Sloan Kettering Cancer Center dedicated to developing immunotherapy for the management of sarcoma and Merkel cell carcinoma.  As leader of the sarcoma specific translational immunotherapy research program, I aim to systematically explore novel combination strategies including, but not limited to checkpoint blockade and adoptive T-cell therapy while identifying biomarkers of response and resistance.